NCT03603223 2025-07-30
Pembrolizumab in Treating Participants With Leukoplakia
Jonsson Comprehensive Cancer Center
Phase 2 Recruiting
Clinical Trials
3 trialsNCT03990636 2019-06-19
PDTMALAC
Instituto Nacional de Cancer, Brazil
Phase 2 Unknown
NCT00001698 2008-03-04
Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR
National Institutes of Health Clinical Center (CC)
Phase 2 Completed